Morphological Changes in Bone Marrow Post Imatinib Therapy in Chronic Phase CML: A Follow up Study on Sequential Bone Marrow Aspirates and Biopsies

INTRODUCTION: Imatinib mesylate is used extensively for first line treatment of Chronic Myeloid Leukemia (CML). However, not many studies have documented morphological changes in bone marrow biopsies produced during Imatinib therapy with reference to myelofibrosis. AIM: To document the morphological...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Diagn Res
Egile Nagusiak: Narang, Neha Chopra, Rusia, Usha, Sikka, Meera, Kotru, Mrinalini
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: JCDR Research and Publications (P) Limited 2017
Gaiak:
Pathology Section
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5449791/
https://ncbi.nlm.nih.gov/pubmed/28571145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2017/25173.9650
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak